NeurAxis, Inc. ( NRXS) - Key Metrics
NRXS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.16 | -$0.19 | -$0.08 | -$0.09 |
| 2026Q1 | $0.15 | -$0.16 | -$0.11 | -$0.11 |
| 2025Q4 | $0.11 | -$0.19 | -$0.21 | -$0.21 |
| 2025Q3 | $0.08 | -$0.21 | -$0.14 | -$0.14 |
| 2025Q2 | $0.10 | -$0.20 | -$0.17 | -$0.17 |
NRXS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0.00% | -9.62 |
| 2026Q1 | 0% | -10.28 |
| 2025Q4 | 0% | -7.09 |
| 2025Q3 | 0% | -3.21 |
| 2025Q2 | 0% | -2.75 |
NRXS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | -1.17% | 0.00% |
| 2026Q1 | -1.52% | 0% |
| 2025Q4 | -4.70% | 0% |
| 2025Q3 | -4.69% | 0% |
| 2025Q2 | -7.15% | 0% |
NRXS
Price: $7.70
52 week price:
Earnings Per Share: -0.76 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 88.7 million